Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin P Alyea

Showing results (41-50 of 176) with videos related to

Pageof 18
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2002
ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destructionF Stephen Hodi, Jan C Schmollinger, Robert J Soiffer, et al.
Blood|May 31, 2002
Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myelomaRoberto Bellucci, Edwin P Alyea, Edie Weller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 16, 2011
Hyperlipidemia and statin use after allogeneic hematopoietic stem cell transplantationBradley W Blaser, Haesook T Kim, Edwin P Alyea, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2015
Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcomeHaesook T Kim, Philippe Armand, David Frederick, et al.
Blood|October 28, 2006
Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosisRoberto Bellucci, Sabine Oertelt, Meagan Gallagher, et al.
Blood|February 5, 2005
Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptorRoberto Bellucci, Edwin P Alyea, Sabina Chiaretti, et al.
Blood|October 24, 2002
A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantationEphraim P Hochberg, David B Miklos, Donna Neuberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host diseaseDaniel J DeAngelo, Ephraim P Hochberg, Edwin P Alyea, et al.
Blood|June 24, 2005
Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host diseaseEmmanuel Zorn, Haesook T Kim, Stephanie J Lee, et al.
Haematologica|June 20, 2015
Efficacy of immune suppression tapering in treating relapse after reduced intensity allogeneic stem cell transplantationNatasha Kekre, Haesook T Kim, Gita Thanarajasingam, et al.
Pageof 18

Showing results (41-50 of 176) with videos related to

Sort By:
Pageof 18
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2002
ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destructionF Stephen Hodi, Jan C Schmollinger, Robert J Soiffer, et al.
Blood|May 31, 2002
Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myelomaRoberto Bellucci, Edwin P Alyea, Edie Weller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 16, 2011
Hyperlipidemia and statin use after allogeneic hematopoietic stem cell transplantationBradley W Blaser, Haesook T Kim, Edwin P Alyea, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2015
Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcomeHaesook T Kim, Philippe Armand, David Frederick, et al.
Blood|October 28, 2006
Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosisRoberto Bellucci, Sabine Oertelt, Meagan Gallagher, et al.
Blood|February 5, 2005
Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptorRoberto Bellucci, Edwin P Alyea, Sabina Chiaretti, et al.
Blood|October 24, 2002
A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantationEphraim P Hochberg, David B Miklos, Donna Neuberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host diseaseDaniel J DeAngelo, Ephraim P Hochberg, Edwin P Alyea, et al.
Blood|June 24, 2005
Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host diseaseEmmanuel Zorn, Haesook T Kim, Stephanie J Lee, et al.
Haematologica|June 20, 2015
Efficacy of immune suppression tapering in treating relapse after reduced intensity allogeneic stem cell transplantationNatasha Kekre, Haesook T Kim, Gita Thanarajasingam, et al.
Pageof 18